Cite
MLA Citation
Priya Kumthekar et al.. “LPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL DISEASE (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL RECEPTOR-2 POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY.” Neuro-oncology advances, vol. 1, n.d., p. i6. http://access.bl.uk/ark:/81055/vdc_100117173713.0x000004